Monotherapy of ceftazidime–avibactam and ceftolozane–tazobactam against multidrug-resistant organisms

Adnan Alatoom

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)126
Number of pages1
JournalInternational Journal of Infectious Diseases
Volume62
DOIs
StatePublished - Sep 1 2017

Fingerprint

tazobactam drug combination ceftolozane
ceftazidime drug combination avibactam

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Monotherapy of ceftazidime–avibactam and ceftolozane–tazobactam against multidrug-resistant organisms. / Alatoom, Adnan.

In: International Journal of Infectious Diseases, Vol. 62, 01.09.2017, p. 126.

Research output: Contribution to journalLetter

@article{4b69dac93adf43ab9e1367e7942bd3cf,
title = "Monotherapy of ceftazidime–avibactam and ceftolozane–tazobactam against multidrug-resistant organisms",
author = "Adnan Alatoom",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.ijid.2017.06.022",
language = "English (US)",
volume = "62",
pages = "126",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Monotherapy of ceftazidime–avibactam and ceftolozane–tazobactam against multidrug-resistant organisms

AU - Alatoom, Adnan

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85026209289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026209289&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2017.06.022

DO - 10.1016/j.ijid.2017.06.022

M3 - Letter

C2 - 28676348

AN - SCOPUS:85026209289

VL - 62

SP - 126

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -